[The expected cost of cancer in Chile].

IF 0.5 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Manuel A Espinoza, Nicolás Armijo, Tomás Abbott, Jorge Jiménez, Carlos Balmaceda
{"title":"[The expected cost of cancer in Chile].","authors":"Manuel A Espinoza,&nbsp;Nicolás Armijo,&nbsp;Tomás Abbott,&nbsp;Jorge Jiménez,&nbsp;Carlos Balmaceda","doi":"10.4067/S0034-98872022001101438","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cancer is a public health priority in Chile.</p><p><strong>Aim: </strong>To estimate the expected annual cost of cancer in Chile, due to direct costs of health services, working allowances and indirect costs for productivity losses.</p><p><strong>Material and methods: </strong>We undertook an ascendent costing methodology to calculate direct costs. We built diagnostic, treatment and follow-up cost baskets for each cancer type. Further, we estimated the expenditure due to sick leave subsidies. Both estimates were performed either for the public or private sector. Costs related to productivity loss were estimated using the human capital approach, incorporating disease related absenteeism premature deaths. The time frame for all estimates was one year.</p><p><strong>Results: </strong>The annual expected costs attributed to cancer was $1,557 billion of Chilean pesos. The health services expected annual costs were $1,436 billion, 67% of which are spent on five cancer groups (digestive, hematologic, respiratory, breast and urinary tract). The expected costs of sick leave subsidies and productivity loss were $48 and $71 billion, respectively.</p><p><strong>Conclusions: </strong>Cancer generates costs to the health system, which obliges health planners to allocate a significant proportion of the health budget to this disease. The expected costs estimated in this study are equivalent to 8.9% of all health expenditures and 0.69% of the Gross Domestic Product. This study provides an updated reference for future research, such as those aimed at evaluating the current health policies in cancer.</p>","PeriodicalId":21360,"journal":{"name":"Revista medica de Chile","volume":null,"pages":null},"PeriodicalIF":0.5000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica de Chile","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4067/S0034-98872022001101438","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cancer is a public health priority in Chile.

Aim: To estimate the expected annual cost of cancer in Chile, due to direct costs of health services, working allowances and indirect costs for productivity losses.

Material and methods: We undertook an ascendent costing methodology to calculate direct costs. We built diagnostic, treatment and follow-up cost baskets for each cancer type. Further, we estimated the expenditure due to sick leave subsidies. Both estimates were performed either for the public or private sector. Costs related to productivity loss were estimated using the human capital approach, incorporating disease related absenteeism premature deaths. The time frame for all estimates was one year.

Results: The annual expected costs attributed to cancer was $1,557 billion of Chilean pesos. The health services expected annual costs were $1,436 billion, 67% of which are spent on five cancer groups (digestive, hematologic, respiratory, breast and urinary tract). The expected costs of sick leave subsidies and productivity loss were $48 and $71 billion, respectively.

Conclusions: Cancer generates costs to the health system, which obliges health planners to allocate a significant proportion of the health budget to this disease. The expected costs estimated in this study are equivalent to 8.9% of all health expenditures and 0.69% of the Gross Domestic Product. This study provides an updated reference for future research, such as those aimed at evaluating the current health policies in cancer.

[智利癌症的预期成本]。
背景:癌症是智利的公共卫生重点。目的:估计智利每年癌症的预期费用,包括保健服务的直接费用、工作津贴和生产力损失的间接费用。材料和方法:我们采用了一种上升的成本计算方法来计算直接成本。我们为每种癌症类型建立了诊断、治疗和随访的费用篮子。此外,我们估计了由于病假补贴的支出。这两项估计都是针对公共或私营部门进行的。利用人力资本方法估算了与生产力损失有关的成本,其中包括与疾病有关的缺勤和过早死亡。所有估算的时间框架都是一年。结果:每年癌症的预期成本为1.557亿智利比索。预计每年的卫生服务费用为1.436万亿美元,其中67%用于五类癌症(消化、血液、呼吸、乳腺癌和泌尿系统)。病假补贴和生产力损失的预期成本分别为480亿美元和710亿美元。结论:癌症给卫生系统带来了成本,这迫使卫生规划人员将卫生预算的很大一部分分配给这种疾病。本研究估计的预期费用相当于所有卫生支出的8.9%和国内生产总值的0.69%。这项研究为未来的研究提供了最新的参考,例如那些旨在评估当前癌症卫生政策的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Revista medica de Chile
Revista medica de Chile 医学-医学:内科
CiteScore
1.20
自引率
16.70%
发文量
75
审稿时长
3-6 weeks
期刊介绍: La Revista Médica de Chile publica trabajos originales sobre temas de interés médico y de Ciencias Biomédicas, dando preferencia a los relacionados con la Medicina Interna y sus especialidades derivadas. Publicada mensualmente, desde 1872, por la Sociedad Médica de Santiago. La abreviatura de su título es Rev Med Chile, que debe ser usado en bibliografías, notas al pié de página, leyendas y referencias bibliográficas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信